Research location
Chiefland
Florida, United States
Advertisement
Research activity in Chiefland
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 39 trials and 40 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Chiefland
39 linked trials · page 1 of 1A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDNCT04320342 · 2022-04-27 · 1 site observation
COMPLETED
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)NCT04636814 · 2021-07-12 · 1 site observation
TERMINATED
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or ObesityNCT03548935 · 2018-06-04 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerNCT02980133 · 2016-12-28 · 1 site observation
COMPLETED
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusNCT02773368 · 2016-05-23 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)NCT02727660 · 2016-04-29 · 1 site observation
COMPLETED
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesNCT02730377 · 2016-03-28 · 1 site observation
COMPLETED
Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.NCT02487498 · 2015-07-27 · 1 site observation
COMPLETED
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes MellitusNCT02229383 · 2014-09-06 · 1 site observation
COMPLETED
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryNCT02155660 · 2014-06-25 · 1 site observation
COMPLETED
A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesNCT02030600 · 2014-01-06 · 1 site observation
COMPLETED
Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and MetforminNCT01907854 · 2013-12-02 · 1 site observation
COMPLETED
Safety and Tolerability of Initiating LCZ696 in Heart Failure PatientsNCT01922089 · 2013-11-01 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsNCT01730534 · 2013-04-25 · 1 site observation
COMPLETED
A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.NCT01727141 · 2012-11-01 · 1 site observation
COMPLETED
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesNCT01606007 · 2012-07-01 · 1 site observation
COMPLETED
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesNCT01619059 · 2012-06-01 · 1 site observation
COMPLETED
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromideNCT01543919 · 2012-04-01 · 2 site observations
COMPLETED
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)NCT01443845 · 2011-09-30 · 1 site observation
COMPLETED
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-studyNCT01194830 · 2010-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 DiabetesNCT01011868 · 2009-11-01 · 1 site observation
COMPLETED
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsNCT00909779 · 2009-06-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 DiabetesNCT00909597 · 2009-05-01 · 1 site observation
COMPLETED
Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes MellitusNCT00814294 · 2008-12-01 · 1 site observation
COMPLETED
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.NCT00744367 · 2008-10-01 · 1 site observation
COMPLETED
Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation
COMPLETED
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 DiabeticsNCT00698230 · 2008-05-01 · 1 site observation
COMPLETED
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusNCT00519142 · 2007-08-01 · 1 site observation
COMPLETED
Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With MetforminNCT00484419 · 2007-05-01 · 1 site observation
COMPLETED
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes MellitusNCT00418522 · 2007-03-01 · 1 site observation
COMPLETED
A Study of Aleglitazar in Patients With Type 2 DiabetesNCT00388518 · 2006-11-01 · 1 site observation
COMPLETED
Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving MethotrexateNCT00369928 · 2006-08-01 · 1 site observation
COMPLETED
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's DiseaseNCT00257673 · 2005-11-01 · 1 site observation
COMPLETED
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00097877 · 2005-01-01 · 1 site observation
COMPLETED
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With AsthmaNCT00139659 · 2003-01-01 · 1 site observation
COMPLETED
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPDNCT00138671 · 2003-01-01 · 1 site observation
TERMINATED
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 DiabetesNCT00136916 · 2002-06-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.